logo
  • Downloads
  • Client Login
  • About Us
    • Why DesertSci?
    • Our History
    • Our Approach
    • Our Clients
    • Publications
    • Contact Us
  • Products
    • Proasis4: Protein Structure Database
    • ViewContacts: Non-Covalent Interactions
    • Scorpion: Scoring
    • Viper: Automated Ligand Design
    • Machine Learning: Next Level Scoring
    • ProFusion: Collaboration
    • FELIX: Drug Repurposing
    • Spinifex: Chemical Similarity
    • BMOS: MOS for Large Datasets
  • Software Modules
    • Atom-Based Binding Site Clustering
    • Antibody Structure Based Drug Discovery
    • Antibody Complementarity Determining Regions
    • Antibody-Antigen Interactions
    • Residue Flexibility
    • WaterRank
    • WaterView
  • Modelling Support
  • Licensing
  • Latest News
Home > Our Products > Machine Learning: Next Level Scoring

  • Proasis4: Protein Structure Database
  • ViewContacts: Non-Covalent Interactions
  • Scorpion: Scoring
  • Viper: Automated Ligand Design
  • FELIX: Drug Repurposing
  • ProFusion: Collaboration
  • Machine Learning: Next Level Scoring
  • Spinifex: Chemical Similarity
  • BMOS: MOS for Large Datasets
logo

Machine Learning: Next Level Scoring of Ligand Binding Affinity

Machine learning and AI dominate recent developments in computing.  DesertSci is uniquely placed to apply ML/AI in the field of scoring protein-ligand binding affinity.

With Scorpion, our empirical scoring function developed in collaboration with top experts in the field, we have unparalleled know-how in building ranking methods.

With Proasis, our protein-structure database system, we have extensive knowledge in working with large quantities of 3D protein-ligand coordinate data.

Together, with new AI technology, we will unlock the key factors driving tight ligand binding … ranking better, faster.  Our software will identify the top drug candidates, among a sea of others, and deliver them to your scientists all day, every day.

Better Ranking = Better Drug Candidates in Larger Quantities

Meaning  real savings, in both time and money, during the early stage drug discovery process.

We are creating a ranking scheme based purely on protein structure data rather than relying on experimental affinity data, because the latter is severely limited by the availability of high-quality data. Furthermore, our strategy focuses on creating a ranking scheme based on non-covalent interactions, network descriptors, and protein flexibility.

Our ML technologies are a work in progress but early results are extremely promising.  We are developing the technology at a fast pace and look forward to testing our methods extensively amongst the Desertsci user community.

Watch this space …

 

icon

News & Events

19 May 2025

Unlocking the Potential of Bioinformatics and Cheminformatics in Structure-Based Drug Design

17 Apr 2025

Data as a Product for Structure-Based Drug Design (SBDD)

19 Mar 2025

AI in drug discovery: Overcoming the scoring barrier.

19 Mar 2025

Removing friction in Structure-Based Drug Design through advanced molecular dynamics.

more articles
image

Looking for FREE Academic Software?

find out more
Logo
  • contact
  • desertsci
  • info@www.desertsci.com

    Ph: +612 8860 6466

    Fax: +612 9680 7520

    © 2011-2025 Desert Scientific Software

    • About Us
    • Our Products
    • Software Modules
    • Modelling Support
    • Licensing
    • News & Events
    Website by The Walk